LKT Labs

Biochemicals for Life Science Research

Incensol

Incensol

Product ID I524086
Cas No. 22419-74-5
Purity ≥98%
Product Unit SizeCostQuantityStock
1 mg $120.00 Please Inquire
5 mg $338.00 Please Inquire
10 mg $601.00 Please Inquire
Bulk Quote

Quicklinks

Description

Incensol is a natural constituent found in frankincense resin and is a potent bioactive diterpenic cembrenoid. Frankincense extract has traditionally been used to treat various inflammatory diseases including arthritis. Several of the individual components in frankincense, including incensol, have shown anti-inflammatory activity in mice. Incensol was found to activate transient receptor potential vanilloid 3, a protein that is involved in temperature sensation in the skin, hair growth, and neurological activities. Incensol has also been found to inhibit activation of Burkitt’s lymphoma derived Raji cells.

Product Info

Cas No.

22419-74-5
Purity

≥98%
Formula

C20H34O2
Formula Wt.

306.49
Chemical Name

(1R,2S,5E,9E,12S)-1,5,9-Trimethyl-12-propan-2-yl-15-oxabicyclo[10.2.1]pentadeca-5,9-dien-2-ol
IUPAC Name

1,5,9-trimethyl-12-propan-2-yl-15-oxabicyclo[10.2.1]pentadeca-5,9-dien-2-ol
Synonym

Incensole, (-)-Incensol, (-)-Incensole
Solubility

Soluble in DMSO, dichloromethane or ethyl ether. Insoluble in water. Almost insoluble in ethanol or methanol.

Shipping and Storage

Store Temp

-20°C
Ship Temp

Ambient

Downloads

MSDS

I524086 MSDS PDF
Info Sheet

I524086 Info Sheet PDF

References

Banno N, Akihisa T, Yasukawa K, et al. Anti-inflammatory activities of the triterpene acids from the resin of Boswellia carteri. J Ethnopharmacol. 2006 Sep 19;107(2):249-253. PMID: 16621377.

Pollastro F, Golin S, Chianese G, et al. Neuroactive and anti-inflammatory frankincense cembranes: a structure-activity study. J Nat Prod. 2016 Jul 22;79(7):1762-1768. PMID: 27352042.

Akihisa T, Tabata K, Banno N, et al. Cancer chemopreventive effects and cytotoxic activities of the triterpene acids from the resin of Boswellia carteri. Biol Pharm Bull. 2006 Sep;29(9):1976-1979. PMID: 16945622.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • I611325

    IPI-549

    Selective inhibitor of the γ isoform of PI3K (...

    ≥98%
  • C0266

    Capsaicin, natural

    Found in Capsicum; TRPV agonist.

    ≥95%, capsaicinoids content
  • S9754

    Syntide 2

    Synthetic peptide, CDPK, PKC, CaMKII substrate....

    ≥95%
  • M0113

    Madecassoside

    Triterpenoid found in Centella.

    ≥90%
  • P005095

    N-Debenzoylpaclitaxel

    Paclitaxel derivative

    ≥95%
  • I5210

    INCB018424

    JAK1/2 inhibitor.

    ≥98%
  • C9662

    Cyproterone Acetate

    Steroid; AR antagonist.

    ≥98%
  • M1579

    Methazolamide

    Carbonic anhydrase inhibitor.

    ≥98%
  • C104761

    CCT-196969

    pan-Raf inhibitor.

    ≥98%
  • D3356

    Diosmetin

    O-methylated flavone found in vetch and various...

    ≥98%
  • P2002

    PF-04691502 Dihydrate

    PI3K and mTOR inhibitor.

    ≥98%
  • V182685

    Verdinexor

    CRM1/XPO1 inhibitor.

    ≥99%
  • J023736

    (±)-Jasmonic Acid

    Phytohormone

    ≥98% (sum of isomers)
  • C1609

    Cecropin B

    Antimicrobial peptide found in Hyalophora cecro...

    ≥95%
  • S8169

    Suramin Hexasodium

    RyR agonist, SIRT, telomerase, P2Y, GPCR inhibi...

    ≥98%
  • A7669

    A-type Natriuretic Peptide (1-28), rat

    Endogenous cardiomodulatory peptide; NPR-A agon...

    ≥95%
  • S041001

    SB-202190

    Highly selective inhibitor

    ≥99%
  • G720009

    GS-9901

    Selective inhibitor of the delta isoform of PI3...

    ≥99%
  • R0110

    Ractopamine Hydrochloride

    β1/2-adrenergic agonist.

    ≥97%
  • T1002

    2-Debenzoyl Paclitaxel-2-(2-Methyl-2-Butenoate)

    Synthesis intermediate

    ≥95%